Wnt/β-catenin signaling and kidney fibrosis

Kidney International Supplements

Volumn 4, Issue 1, 2014, Pages 84-90

  Tan, Roderick J ^a   Zhou, Dong ^a   Zhou, Lili ^b   Liu, Youhua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Guangdong Institute of Standardization   (China)

Author keywords

fibroblasts; proteinuria; renal fibrosis; Wnt; catenin

Indexed keywords

BETA CATENIN; WNT PROTEIN;

GLOMERULOSCLEROSIS; HUMAN; KIDNEY FIBROSIS; KIDNEY INJURY; PATHOGENESIS; PODOCYTE; PROTEIN TARGETING; REVIEW; WNT SIGNALING PATHWAY;

EID: 84908499000     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2014.16     Document Type: Short Survey

References (62)

1. Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 2009; 10: 468-477.
2. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006; 25: 7469-7481.
3. Schmidt-Ott KM, Barasch J. WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny. Kidney Int 2008; 74: 1004-1008.
4. Kawakami T, Ren S, Duffield JS. Wnt signalling in kidney diseases: dual roles in renal injury and repair. J Pathol 2013; 229: 221-231.
5. Dai C, Stolz DB, Kiss LP et al. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 2009; 20: 1997-2008.
6. He W, Dai C, Li Y et al. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 765-776.
7. Surendran K, Schiavi S, Hruska KA. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 2005; 16: 2373-2384.
8. Hwang I, Seo EY, Ha H. Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Arch Pharm Res 2009; 32: 1653-1662.
9. Rao TP, Kuhl M. An updated overview on Wnt signaling pathways: a prelude for more. Circ Res 2010; 106: 1798-1806.
10. Karner CM, Chirumamilla R, Aoki S et al. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat Genet 2009; 41: 793-799.
11. Burn SF, Webb A, Berry RL et al. Calcium/NFAT signalling promotes early nephrogenesis. Dev Biol 2011; 352: 288-298.
12. Ren S, Johnson BG, Kida Y et al. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci USA 2013; 110: 1440-1445.
13. Liu H, Fergusson MM, Castilho RM et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007; 317: 803-806.
14. Satoh M, Nagasu H, Morita Y et al. Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling. Am J Physiol Renal Physiol 2012; 303: F1641-F1651.
15. Nagaoka T, Karasawa H, Turbyville T et al. Cripto-1 enhances the canonical Wnt/beta-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors. Cell Signal 2013; 25: 178-189.
16. Wang D, Dai C, Li Y et al. Canonical Wnt/beta-catenin signaling mediates transforming growth factor-beta1-driven podocyte injury and proteinuria. Kidney Int 2011; 80: 1159-1169.
17. Kang YS, Li Y, Dai C et al. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 2010; 78: 363-373.
18. Mei JM, Borchert GL, Donald SP et al. Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex. Carcinogenesis 2002; 23: 2119-2122.
19. Kim H, He Y, Yang I et al. delta-Catenin promotes E-cadherin processing and activates beta-catenin-mediated signaling: implications on human prostate cancer progression. Biochim Biophys Acta 2012; 1822: 509-521.
20. Zhou D, Li Y, Lin L et al. Tubule-specific ablation of endogenous betacatenin aggravates acute kidney injury in mice. Kidney Int 2012; 82: 537-547.
21. Lin SL, Li B, Rao S et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci USA 2010; 107: 4194-4199.
22. Kato H, Gruenwald A, Suh JH et al. Wnt/beta-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J Biol Chem 2011; 286: 26003-26015.
23. von Toerne C, Schmidt C, Adams J et al. Wnt pathway regulation in chronic renal allograft damage. Am J Transplant 2009; 9: 2223-2239.
24. Hao S, He W, Li Y et al. Targeted inhibition of beta-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 2011; 22: 1642-1653.
25. Zhou L, Li Y, Zhou D et al. Loss of Klotho contributes to kidney injury by derepression of Wnt/beta-catenin signaling. J Am Soc Nephrol 2013; 24: 771-785.
26. Toualbi K, Guller MC, Mauriz JL et al. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes. Oncogene 2007; 26: 3492-3502.
27. Koehler A, Schlupf J, Schneider M et al. Loss of Xenopus cadherin-11 leads to increased Wnt/beta-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest. Dev Biol 2013; 383: 132-145.
28. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684-696.
29. Boutet A, De Frutos CA, Maxwell PH et al. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 2006; 25: 5603-5613.
30. Yoshino J, Monkawa T, Tsuji M et al. Snail1 is involved in the renal epithelial-mesenchymal transition. Biochem Biophys Res Commun 2007; 362: 63-68.
31. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12.
32. Li Y, Wen X, Liu Y. Tubular cell dedifferentiation and peritubular inflammation are coupled by the transcription regulator Id1 in renal fibrogenesis. Kidney Int 2012; 81: 880-891.
33. Garcia de Herreros A, Baulida J. Cooperation, amplification, and feed-back in epithelial-mesenchymal transition. Biochim Biophys Acta 2012; 1825: 223-228.
34. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4: 617-629.
35. Tan RJ, Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Renal Physiol 2012; 302: F1351-F1361.
36. Surendran K, Simon TC, Liapis H et al. Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4. Kidney Int 2004; 65: 2212-2222.
37. He W, Tan RJ, Li Y et al. Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/beta-catenin activity in CKD. J Am Soc Nephrol 2012; 23: 294-304.
38. Eddy AA, Fogo AB. Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 2006; 17: 2999-3012.
39. Kitching AR, Kong YZ, Huang XR et al. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol 2003; 14: 1487-1495.
40. Nicholas SB, Aguiniga E, Ren Y et al. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney Int 2005; 67: 1297-1307.
41. Oda T, Jung YO, Kim HS et al. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 2001; 60: 587-596.
42. He W, Tan R, Dai C et al. Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling. J Biol Chem 2010; 285: 24665-24675.
43. Cao W, Zhou QG, Nie J et al. Albumin overload activates intrarenal reninangiotensin system through protein kinase C and NADPH oxidasedependent pathway. J Hyperten 2011; 29: 1411-1421.
44. Freundlich M, Quiroz Y, Zhang Z et al. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 2008; 74: 1394-1402.
45. Ng HY, Tain YL, Lee YT et al. Renin angiotensin system blockade ameliorates lead nephropathy. Biochem Biophys Res Commun 2013; 438: 359-363.
46. Chen S, Ge Y, Si J et al. Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade. Kidney Int 2008; 74: 1128-1138.
47. Naves MA, Requiao-Moura LR, Soares MF et al. Podocyte Wnt/ ss-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis. J Nephrol 2012; 25: 401-409.
48. He W, Kang YS, Dai C et al. Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 2011; 22: 90-103.
49. Kriz W, Shirato I, Nagata M et al. The podocyte's response to stress: the enigma of foot process effacement. Am J Physiol Renal Physiol 2013; 304: F333-F347.
50. Brinkkoetter PT, Ising C, Benzing T. The role of the podocyte in albumin filtration. Nat Rev Nephrol 2013; 9: 328-336.
51. D'Agati VD. Podocyte injury in focal segmental glomerulosclerosis: lessons from animal models (a play in five acts). Kidney Int 2008; 73: 399-406.
52. Li Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008; 172: 299-308.
53. Reiser J, Polu KR, Moller CC et al. TRPC6 is a glomerular slit diaphragmassociated channel required for normal renal function. Nat Genet 2005; 37: 739-744.
54. Winn MP, Conlon PJ, Lynn KL et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308: 1801-1804.
55. Li Z, Xu J, Xu P et al. Wnt/beta-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes. Cell Prolif 2013; 46: 76-85.
56. Jiang L, Xu L, Song Y et al. Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/beta-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria. J Biol Chem 2013; 288: 23368-23379.
57. Kim MS, Yoon SK, Bollig F et al. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway. J Biol Chem 2010; 285: 14585-14593.
58. de Borst MH, Hajhosseiny R, Tamez H et al. Active vitamin D treatment for reduction of residual proteinuria: a systematic review. J Am Soc Nephrol 2013; 24: 1863-1871.
59. Kim CS, Joo SY, Lee KE et al. Paricalcitol attenuates 4-hydroxy-2-hexenalinduced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. PLoS ONE 2013; 8: e63186.
60. DiRocco DP, Kobayashi A, Taketo MM et al. Wnt4/beta-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol 2013; 24: 1399-1412.
61. Ma H, Nguyen C, Lee KS et al. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene 2005; 24: 3619-3631.
62. Henderson WR Jr., Chi EY, Ye X et al. Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci USA 2010; 107: 14309-14314.